Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors

Clinical trial NCT03991832 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03991832
Sponsor: University Health Network, Toronto
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Glioma Cholangiocarcinoma Solid Tumor IDH Mutation

Start date: 2019-12-31
Primary completion: 2026-09-30
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.